approval
saveKEYTRUDA QLEX (PEMBROLIZUMAB) — FDA approval
community read0 votes
Sponsor: MERCK SHARP DOHME. Form: INJECTABLE. Route: INJECTION
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 4
same company · ±60 days · 6
- approvalpembrolizumab: KEYTRUDA (PEMBROLIZUMAB) — FDA approvalFeb 10, 2026
- approvalPOSACONAZOLE: NOXAFIL (POSACONAZOLE) — FDA approvalJan 27, 2026
- approvalPOSACONAZOLE: NOXAFIL (POSACONAZOLE) — FDA approvalJan 27, 2026
- recallMerck Sharp & Dohme LLC recall (Cls II)Dec 31, 2025
- recallMerck Sharp & Dohme LLC recall (Cls II)Dec 31, 2025
- approvalsotatercept: WINREVAIR (SOTATERCEPT-CSRK) — FDA approvalMar 25, 2026
comments(0)
5-min edit window · permanent after that